Podocyte Density Loss Estimate from Biopsy

Estimate podocyte depletion from renal biopsy morphometry using podocyte number per glomerulus and podocyte density, which predicts FSGS development and CKD progression.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate podocyte depletion from renal biopsy morphometry using podocyte number per glomerulus and podocyte density, which predicts FSGS development and CKD progression

Each component has a specific meaning:

  • Renal biopsy morphometry — The renal biopsy morphometry recorded for the scenario being assessed.

Note: Interpret the podocyte density estimate result against the thresholds and context described above.

How to Use

Enter the renal biopsy morphometry for the scenario you are assessing. Estimate podocyte depletion from renal biopsy morphometry using podocyte number per glomerulus and podocyte density, which predicts FSGS development and CKD progression. Use the podocyte density estimate result to inform your calculation.

Related Calculators

UACR Risk Stratification

Hyper-niche Medical

Frequently Asked Questions